Clinical Characterization, Risk Factors, and Mortality in Patients with Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Intra-Abdominal Infections

耐碳青霉烯类高毒力肺炎克雷伯菌腹腔内感染患者的临床特征、危险因素和死亡率

阅读:2

Abstract

BACKGROUND: The outbreak of the highly lethal Carbapenem-resistant Klebsiella pneumoniae (CR-hvKP) strain is increasingly prevalent. The aim of this study was to investigate the epidemiology, molecular characteristics, and mortality rate in intra-abdominal infections (IAIs) caused by CR-hvKP in a tertiary hospital, providing scientific evidence for clinical treatment to reduce mortality and improve patient prognosis. METHODS: The study included 160 patients who developed CRKP IAIs from June 2023 to December 2024. Carbapenemase and virulence genes were detected by Polymerase chain reaction assay. Antimicrobial susceptibility test was performed to determine drug resistance. Multivariate logistic regression and multivariate Cox regression were used to determine risk factors of CR-hvKP IAIs and CRKP IAIs mortality, respectively. RESULTS: A total of 160 patients with CRKP IAIs were enrolled: 68 with CR-hvKP IAIs and 92 with CR-non-hvKP IAIs. The mortality rate trended higher in the CR-hvKP group compared with CR-non-hvKP (17.6% vs 10.9%), but the difference was not statistically significant (P=0.218). Multivariate logistic regression identified tracheotomy as a risk factor for infection with CR-hvKP IAIs (OR 2.816, 95% CI 1.120-7.080). Multivariate Cox regression analysis identified four independent risk factors for in-hospital mortality of CRKP IAIs: age (HR 1.066, 95% CI 1.020-1.114), decreased platelet count (HR 0.995, 95% CI 0.990-0.999), septic shock (HR 9.141, 95% CI 2.082-40.133), and tracheotomy (HR 4.322, 95% CI 1.461-12.791). CONCLUSION: The mortality rate was numerically higher in the CR-hvKP IAIs while the difference was not statistically significant. Our study identified tracheotomy as an independent risk factor for infection with CR-hvKP IAIs. Clinicians need to enhance their awareness and epidemiologic surveillance of this lethal bacterium.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。